Pfizer acquires Arena Pharmaceuticals Arena Pharmaceuticals from 3/11/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Arena Pharmaceuticals for $6.7 billion, or $100 a share.

Arena Pharmaceuticals

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS-Bank's profit increased by more than 30% in the first quarter%

5/17/24 MBNK

Bank Saint Petersburg reports for the first quarter of 2024

5/17/24 BSPB

Shareholders of Rosbank approved dividends for 2023

5/17/24 ROSB

Shareholders of Chelyabinsk Press-Forging Plant approved dividends for 2023

5/17/24 CHKZ

HeadHunter can launch its own social network in the summer

5/17/24 HHRU

Shareholders of Perm Energy Supply Company approved dividends for 2023

5/16/24 PMSB

Kamaz develops its own tourist bus

5/16/24 KMAZ

The Board of Directors of Leeuwenhoek recommended paying dividends out of the retained earnings of previous years in the amount of no more than 50 million rubles or ₽0.9445 per ordinary share. The last day of buying securities for receiving dividends is June 27, 2024. The dividend yield may be 1.59%.

5/16/24 LVHK

Rosbank reports for the first quarter of 2023

5/16/24 ROSB

Tinkoff reports for the first quarter of 2024

5/16/24 TCSG